| Title |
|
|
|
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck: an EORTC New Drug Development Group study
| |
| Author |
|
|
|
| |
| Institution/Organisation |
|
|
|
EORTC-New Drug Development Group
| |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
European journal of cancer. - Oxford, 1965 - 1981 | |
| Publication |
|
|
|
Oxford : 2004
| |
| ISSN |
|
|
|
0014-2964 [print]
1879-2995 [online]
| |
| Volume/pages |
|
|
|
40(2004), p. 2748-2752
| |
| ISI |
|
|
|
000225993400022
| |
| Full text (Publisher's DOI) |
|
|
|
| |
|